Hyperliquid Strategies Inc.
PURR
$4.32
$0.061.41%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
2/14/2026
-
MarketBeat
2/12/2026
-
MarketBeat
2/12/2026
-
MarketBeat
2/12/2026
-
The Fly
2/12/2026
-
Ticker Report
2/11/2026
-
MarketBeat
2/11/2026
-
Seeking Alpha - Healthcare
2/11/2026
-
PR Newswire
2/5/2026
-
PR Newswire
2/3/2026
-
Bloomberg Markets and Finance-YouTube
2/3/2026
-
Bloomberg Markets and Finance-YouTube
12/29/2025
-
Invezz News
12/24/2025
-
The Fly
12/16/2025
-
GuruFocus
12/16/2025
-
TipRanks Financial Blog
12/16/2025
-
The Fly
12/16/2025
-
GuruFocus
12/16/2025
-
The Fly
12/8/2025
-
GuruFocus
12/8/2025
-
TipRanks Financial Blog
12/8/2025
-
Globe Newswire
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
--
Net Income (TTM)
--
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
--
Cash from Investing (TTM)
--
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
--
Filings
Filing Date
Wednesday, February 11, 2026
Period Date
Wednesday, December 31, 2025
Next Filing
Week of Feb 8 and 12 (est)
Price History
Beta
--
7-Day Total Return
30-Day Total Return
60-Day Total Return
--
90-Day Total Return
--
Year to Date Total Return
1-Year Total Return
--
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
--
Phone Number
Address
477 Madison Avenue
New York, NY 10022
New York, NY 10022
Country
Year Founded
Business Description
Sector
Hyperliquid Strategies Inc., through its subsidiary, operates as a a biotechnology company that owns a platform for biologic medicines of single or bifunctional action. The company was...
more